BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22872143)

  • 1. Clinical scores to predict recurrence risk of venous thromboembolism.
    Kyrle PA; Eichinger S
    Thromb Haemost; 2012 Dec; 108(6):1061-4. PubMed ID: 22872143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
    Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
    Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous thromboembolism: risk factors for recurrence.
    Zhu T; Martinez I; Emmerich J
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.
    Palareti G; Legnani C; Cosmi B; Valdré L; Lunghi B; Bernardi F; Coccheri S
    Circulation; 2003 Jul; 108(3):313-8. PubMed ID: 12847064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The negative predictive value of D-dimer on the risk of recurrent venous thromboembolism in patients with multiple previous events: a prospective cohort study (the PROLONG PLUS study).
    Ageno W; Cosmi B; Ghirarduzzi A; Santoro R; Bucherini E; Poli D; Prisco D; Alatri A; Pengo V; Galli L; Dentali F; Palareti G
    Am J Hematol; 2012 Jul; 87(7):713-5. PubMed ID: 22488507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Optimal duration of anticoagulation of venous thromboembolism].
    Savina EN; Couturaud F
    J Mal Vasc; 2011 Dec; 36 Suppl 1():S28-32. PubMed ID: 22177766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation after venous thromboembolism. Deciding on the optimal duration.
    Eichinger S
    Hamostaseologie; 2013 Aug; 33(3):211-7. PubMed ID: 23719863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current criteria to determine the duration of anticoagulant therapy].
    Palareti G
    Recenti Prog Med; 2007 Dec; 98(12):603-6. PubMed ID: 18369033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on the predictive value of D-dimer in patients with idiopathic venous thromboembolism.
    Cosmi B; Palareti G
    Thromb Res; 2010 Apr; 125 Suppl 2():S62-5. PubMed ID: 20434008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped.
    Palareti G; Legnani C; Cosmi B; Guazzaloca G; Pancani C; Coccheri S
    Thromb Haemost; 2002 Jan; 87(1):7-12. PubMed ID: 11848459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of anticoagulant therapy for venous thromboembolism: balancing benefits and harms on the long term.
    de Jong PG; Coppens M; Middeldorp S
    Br J Haematol; 2012 Aug; 158(4):433-41. PubMed ID: 22734929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting the risk of recurrent venous thromboembolism. The Austrian study on recurrent venous thromboembolism (AUREC).
    Kyrle PA; Eischer L
    Hamostaseologie; 2013 Aug; 33(3):201-9. PubMed ID: 23712242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidities, alone and in combination with D-dimer, as risk factors for recurrence after a first episode of unprovoked venous thromboembolism in the extended follow-up of the PROLONG study.
    Cosmi B; Legnani C; Tosetto A; Pengo V; Ghirarduzzi A; Testa S; Prisco D; Poli D; Tripodi A; Palareti G; ;
    Thromb Haemost; 2010 Jun; 103(6):1152-60. PubMed ID: 20352167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The optimal duration of anticoagulation in patients with venous thromboembolism: how long is long enough?
    Prandoni P; Piovella C; Spiezia L; Dalla Valle F; Pesavento R
    Panminerva Med; 2012 Mar; 54(1):39-44. PubMed ID: 22278115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-dimer, oral anticoagulation, and venous thromboembolism recurrence.
    Cosmi B; Palareti G
    Semin Vasc Med; 2005 Nov; 5(4):365-70. PubMed ID: 16302157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact and clinical significance of recurrent venous thromboembolism.
    Labropoulos N; Spentzouris G; Gasparis AP; Meissner M
    Br J Surg; 2010 Jul; 97(7):989-99. PubMed ID: 20632262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting recurrent venous thromboembolism in cancer: is it possible?
    Kyrle PA
    Thromb Res; 2014 May; 133 Suppl 2():S17-22. PubMed ID: 24862139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk factors for recurrent venous thromboembolism].
    Rosencher J; Mirault T; Martinez I; Zhu T; Messas E; Emmerich J
    Rev Mal Respir; 2011 Apr; 28(4):453-62. PubMed ID: 21549901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The optimal duration of anticoagulant treatment following pulmonary embolism].
    Couturaud F
    Rev Mal Respir; 2011 Dec; 28(10):1265-77. PubMed ID: 22152935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism.
    Verhovsek M; Douketis JD; Yi Q; Shrivastava S; Tait RC; Baglin T; Poli D; Lim W
    Ann Intern Med; 2008 Oct; 149(7):481-90, W94. PubMed ID: 18838728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.